NT cancer data recorded between 1991-2020 was published by the Medical Journal of Australia last month, showing an ...

While older millennials currently have the the highest rates, researchers believe cases may continue to rise among younger generations.

Results from a first-in-human Phase Ia/Ib trial show that LY4170156 demonstrated a notably high overall response rate in ...

Regulatory action was based on data from the Phase III IMforte trial, which showed that Zepzelca plus Tecentriq significantly ...

Early breast cancer patients have an average economic loss of up to 70 million won or more. In the case of recurrence, it ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Reduce your other risk factors. Tobacco and alcohol use are some of the strongest lifestyle risk factors for head and neck ...